본문 바로가기
  • Home

The Bibiographical investigation of effect of GYPSUM FIBROSUM in Dongyi Soose Bowon

  • Journal of Sasang Constitution and Immune Medicine
  • Abbr : J Sasang Constitut Med
  • 2000, 12(1), pp.110-119
  • Publisher : The Society of Sasang Constitution and Immune Medicine
  • Research Area : Medicine and Pharmacy > Korean Medicine
  • Received : June 30, 2000
  • Accepted : June 30, 2000
  • Published : June 30, 2000

Jung Kwang-hee 1 Koh Byung-Hee 2 Song Il Byoung 2

1경희대학교 한의과대학 사상체질과
2경희대학교

ABSTRACT

1. Purpose and Method We do not have the Sasagn Consitutional Pharmacology exactly. So we use Sasagn Consitutional medical herbs based on the theory of Yin-yang and the five elements herbology. So I try to objectify Sasagn Consitutional Classification of Gypsum Fibrosum in DongyiSooseBowon. Among the soyangin(少陽人) Pyobyung(表病) prescription, Fever MangYin Symptom(fever, headache, diarrhea) prescription include Gypsum Fibrosum, Cold MangYin Symptom(cold, pain in abdomen, diarrhea) prescription does not include Gypsum Fibrosum. So, I to make manifest the spirit of using Gypsum Fibrosum in Soyangin(少陽人) PyoByung(表炳), and the differences of two symptom, and the literature on this subject, I searched oriental medical books. 2. result 1. The management of Gypsum Fibrosum is to grind and make powder. 2. The spirit of using Gypsum Fibrosum in Soyangin(少陽人) Fever MangYi Symptom(fever, headache, diarrhea) prescription is Cleanse the Inside fever and Down the Outside Yin. 3. Fever MangYin Symptom(fever, headache, diarrhea) prescription include Gypsum Fibrosum, Cold MangYin Symptom(cold, pain in abdomen, diarrhea) prescription does not include Gypsum Fibrosum. and The Important syndrome of using Gypsum Fibrosum in Soyangin(少陽人) Fever MangYin Symptom(fever, headache, diarrhea) is fever and headache. 4. Gypsum Fibrosum is The representative herb on Soyangin FeverSymptom. 5. The site of therapeutic action of Gypsum Fibrosum is Wiguk(胃局) - Upper Juncho

KEYWORDS

no data found.

Citation status

* References for papers published after 2023 are currently being built.